Clinical Trial

Implementation and Validation of an Analytical Protocol for Measuring de Novo Lipogenesis in the Liver Using Stable Isotopes

Name: Implementation and Validation of an Analytical Protocol for Measuring de Novo Lipogenesis in the Liver Using Stable Isotopes — clinical trial record (NCT07742423)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: DNL

Completed

View on ClinicalTrials.gov →

Summary

During this study, an analytical protocol for measuring hepatic de novo lipogenesis (DNL) using deuterium oxide (²H₂O) will be implemented and validated in healthy participants.

Trial Details

NCT Number	NCT07742423
Lead Sponsor	KU Leuven
Conditions	De Novo Lipogenesis (DNL), Lipid Metabolism, Stable Isotope Tracing, Healthy Volunteers (HV)
Enrollment	10 participants
Start Date	2025-08-25
Primary Completion	2025-12-11 (estimated)
Study Completion	2025-12-11 (estimated)
Updated on ClinicalTrials.gov	2026-08-03